A Retrospective Study of COVID-19 Treatments

Last updated: February 27, 2024
Sponsor: ProgenaBiome
Overall Status: Completed

Phase

N/A

Condition

Pneumonia

Bronchitis

Lung Injury

Treatment

No Intervention Used

Clinical Study ID

NCT04949230
PRG-051
  • Ages > 18
  • All Genders

Study Summary

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Signed informed consent, demonstrating that the patient understands the proceduresrequired for the study and the purpose of the study
  2. Male or female of 18 years of age or older
  3. Diagnosis of COVID-19 infection by RT- PCR
  4. Recovery from COVID-19

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: No Intervention Used
Phase:
Study Start date:
February 19, 2021
Estimated Completion Date:
February 15, 2024

Study Description

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Connect with a study center

  • Ginger Aurella

    Ventura, California 93003
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.